Opening of a phase Ib/II study to investigate the safety and efficacy of Afatinib in patients with Fanconi anemia and unresectable locally advanced or metastatic head and neck squamous cell carcinoma
Opening of a phase Ib/II study to investigate the safety and efficacy of Afatinib in patients with Fanconi anemia and unresectable locally advanced or metastatic head and neck squamous cell carcinoma
Núria Berga, Xavier León, Ramón Garcı́a-Escudero, E. Moreno et al.
Journal
BMC Cancer
Topics
Cancer-related Molecular Pathways
article
Opening of a phase Ib/II study to investigate the safety and efficacy of Afatinib in patients with Fanconi anemia and unresectable locally advanced or metastatic head and neck squamous cell carcinoma
Núria Berga, Xavier León, Ramón Garcı́a-Escudero, E. Moreno, Jordi Minguillón, Christian P. Kratz, Geòrgia Anguera, Óscar Gallego, Jordi Surrallés, Mireia Llobet
article en
Abstract
No abstract available for this paper.
Publication Tag
BMC CancerVol. 25(1)
Institutions
Universitat Autònoma de Barcelona (ES), Hospital de Sant Pau (ES), Medizinische Hochschule Hannover (DE), Research Institute Hospital 12 de Octubre (ES), Spanish National Cancer Research Centre (ES), Hospital La Paz Institute for Health Research (ES), Centro de Investigación Biomédica en Red de Cáncer (ES), Instituto de Investigación de Enfermedades Raras (ES), Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (ES)